Plasma aldosterone concentration in the patient with diabetes mellitus Rapid Communication
- 1 April 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 65 (4) , 1435-1439
- https://doi.org/10.1111/j.1523-1755.2004.00524.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Aldosterone Function in Diabetes Mellitus: Effects on Cardiovascular and Renal DiseaseJournal of Clinical Endocrinology & Metabolism, 2003
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitusKidney International, 2001
- Effect of Hyperglycaemia on Arterial Pressure, Plasma Renin Activity and Renal Function in Early DiabetesClinical Science, 1996
- Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.Hypertension, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Renal vascular response to interruption of the renin-angiotensin system in normal manKidney International, 1977